SCHEMBL6901584

SCHEMBL6901584

O=C(O)C1=CC(=O)C2=Cc3ccc(C(=O)O)cc3C2=C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TTR P02766 3/20 0.41
▸ PTPRC P08575 2/20 0.40
▸ POLB P06746 4/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ MEN1 O00255 2/20 0.37
▸ GFER P55789 1/20 0.37
▸ TDP2 O95551 1/20 0.36
▸ CA12 O43570 2/20 0.35
▸ CA1 P00915 2/20 0.35
▸ CA2 P00918 2/20 0.35
▸ CA4 P22748 2/20 0.35
▸ CA6 P23280 2/20 0.35
▸ CA7 P43166 2/20 0.35
▸ CA9 Q16790 2/20 0.35
▸ CA14 Q9ULX7 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ L3MBTL1 Q9Y468 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL599579 0.73 TTR (0.44) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL9165999 0.64 TTR (0.57) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL69805 0.64 PTPRC (0.72) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL68062 0.64 PTPRC (0.72) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL598301 0.63 TTR (0.88) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL31436145 0.63 TTR (0.88) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL71021 0.63 TTR (0.88) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL31686219 0.63 PTPRC (0.84) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL31086890 0.63 TTR (0.80) TTRPTPRCPOLBKMT2AMEN1
SCHEMBL600296 0.63 TTR (0.80) TTRPTPRCPOLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6710202-B2 ESTERIFYING CRUDE TEREPHTHALIC ACID WITH ETHYLENE GLYCOL AND/OR ETHYLENE OXIDE, MIXING THE REACTION PRODUCT OBTAINED WITH ETHYLENE GLYCOL AND DEIONIZING THE SOLUTION, DISTILLING OFF LOWER BOILING SUBSTANCES, MOLECULAR DISTILLATION AIES CO., LTD. (JP) 2004-03-23 — — US disclosed
US-20030050499-A1 Process for production of high-purity bis-beta-hydroxyethyl terephthalate PET REBIRTH CO., LTD. (JP) 2003-03-13 — — US disclosed
EP-1254888-A1 PROCESS FOR PRODUCTION OF HIGH-PURITY BIS-BETA-HYDROXYETHYL TEREPHTHALATE Aies Co., Ltd. (JP) 2002-11-06 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030050499-A1 Process for production of high-purity bis-beta-hydroxyethyl terephthalate FHIT, DBH, RPS27A TTR 740/4885PTPRC 4034/4885POLB 160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback